Special Issue "Bioactive Compounds"

Quicklinks

A special issue of Pharmaceuticals (ISSN 1424-8247).

Deadline for manuscript submissions: closed (28 February 2011)

Special Issue Editors

Guest Editor
Dr. Isabel C. F. R. Ferreira
Mountain Research Center, School of Agriculture, Polytechnic Institute of Bragança, Campus de Santa Apolónia, apartado 1172, 5301-855 Bragança, Portugal
E-Mail: iferreira@ipb.pt
Interests: food chemistry; bioactivity of natural products

Guest Editor
Dr. Nancy D. Turner
Department of Nutrition and Food Science, Texas A&M University, Rm. 212C Kleberg Bldg., 2253 TAMU, College Station, TX 77843-2253, USA
E-Mail: n-turner@tamu.edu
Interests: colon cancer; inflammatory bowel disease; bioactive compounds; dietary fiber; apoptosis; microbiota

Special Issue Information

Dear Colleagues,

Consumers increasingly believe that foods contribute directly to their health and well-being. In this context, extranutritional constituents that typically occur in small quantities in foods, "Bioactive compounds¡±, play a very significant role. Bioactive compounds are being intensively studied to evaluate their effects on health, including antioxidant, antiallergic, antimicrobial, antithrombotic, antiatherogenic, hypoglycaemic, anti-inflammatory, antitumor, cytostatic, immunosuppressive properties, and hepatoprotective activities. Contributions for this issue, both in form of original research and review articles, may cover all aspects of bioactive compounds with proven activities in various biological screenings and pharmacological models, e.g. quantification, variability and efficacy of bioactive compounds; development of new protocols and methods based on chemical or biological systems for the evaluation of in vivo and in vitro bioactivity; clinical and nutritional trials focused on the bioactive properties of bioactive compounds synthesized or isolated; elucidation of bioactive compounds mechanisms; innovative techniques of bioactive compounds delivery and protocols for the extraction, isolation, structural characterization of new bioactive compounds will be welcomed, on condition that an adequate evaluation of their efficacy is provided. Papers regarding the development of pharmaceuticals from bioactive compounds will be also taken into consideration.

Dr Isabel C.F.R. Ferreira
Guest Editor

Related Special Issue

Keywords

  • bioactivity
  • natural products
  • synthesised compounds
  • isolation techniques
  • structure elucidation
  • mechanism of action

Published Papers (1 paper)

by ,  and
Pharmaceuticals 2011, 4(4), 590-602; doi:10.3390/ph4040590
Received: 5 January 2011; in revised form: 14 March 2011 / Accepted: 14 March 2011 / Published: 6 April 2011
Show/Hide Abstract | PDF Full-text (279 KB) | HTML Full-text | XML Full-text

Last update: 4 March 2014

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert